Baldwin Wealth Partners LLC MA Has $9.40 Million Stock Holdings in Waters Co. (NYSE:WAT)

Baldwin Wealth Partners LLC MA trimmed its holdings in shares of Waters Co. (NYSE:WAT - Free Report) by 6.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,513 shares of the medical instruments supplier's stock after selling 1,722 shares during the quarter. Baldwin Wealth Partners LLC MA's holdings in Waters were worth $9,403,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in WAT. Aster Capital Management DIFC Ltd bought a new stake in shares of Waters in the 4th quarter valued at $28,000. Bank of Jackson Hole Trust bought a new position in Waters during the fourth quarter worth $34,000. Steward Partners Investment Advisory LLC boosted its stake in Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after acquiring an additional 53 shares in the last quarter. Whipplewood Advisors LLC lifted its stake in shares of Waters by 5,200.0% in the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after buying an additional 104 shares in the last quarter. Finally, Murphy & Mullick Capital Management Corp bought a new stake in Waters in the fourth quarter worth about $42,000. 94.01% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

WAT has been the topic of several research reports. Barclays lowered their price objective on shares of Waters from $400.00 to $350.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Robert W. Baird lifted their price objective on shares of Waters from $355.00 to $374.00 and gave the stock an "outperform" rating in a research report on Wednesday, May 7th. JPMorgan Chase & Co. lifted their price objective on shares of Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a research report on Thursday, March 6th. Bank of America reduced their target price on shares of Waters from $430.00 to $410.00 and set a "neutral" rating for the company in a research note on Thursday, February 13th. Finally, Wells Fargo & Company lifted their target price on shares of Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a research note on Thursday, February 13th. Ten analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $390.19.

Waters Trading Up 1.4%

Shares of Waters stock opened at $351.25 on Monday. Waters Co. has a 1 year low of $279.24 and a 1 year high of $423.56. The firm has a market cap of $20.90 billion, a PE ratio of 32.80, a PEG ratio of 3.79 and a beta of 1.11. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The company has a 50 day simple moving average of $341.26 and a two-hundred day simple moving average of $368.99.

Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.03. Waters had a net margin of 21.56% and a return on equity of 46.31%. The business had revenue of $661.71 million during the quarter, compared to analyst estimates of $655.50 million. During the same period in the previous year, the business posted $2.21 earnings per share. Waters's revenue for the quarter was up 3.9% on a year-over-year basis. Analysts expect that Waters Co. will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.